33 related articles for article (PubMed ID: 38609782)
1. Comprehensive analysis of a novel subtype of immune microenvironment-derived HPV-infected colorectal cancer.
Zhou J; Liu Y; Zhang Y; Ling F; Zheng J; Yao X; Lyu Z; Feng H; Li Y
Microbes Infect; 2024; 26(4):105315. PubMed ID: 38417673
[TBL] [Abstract][Full Text] [Related]
2. Chang Wei Qing Decoction enhances the anti-tumor effect of PD-1 inhibitor therapy by regulating the immune microenvironment and gut microbiota in colorectal cancer.
Wang T; Wu L; Wang S; Shi X; Liu H; Deng W
Chin J Nat Med; 2023 May; 21(5):333-345. PubMed ID: 37245872
[TBL] [Abstract][Full Text] [Related]
3. Faeces from malnourished colorectal cancer patients accelerate cancer progression.
Chao X; Lei Z; Hongqin L; Ziwei W; Dechuan L; Weidong D; Lu X; Haitao C; Bo Z; Haixing J; Qinghua Y
Clin Nutr; 2022 Mar; 41(3):632-644. PubMed ID: 35124471
[TBL] [Abstract][Full Text] [Related]
4. Tissue-Associated Bacterial Alterations in Rectal Carcinoma Patients Revealed by 16S rRNA Community Profiling.
Thomas AM; Jesus EC; Lopes A; Aguiar S; Begnami MD; Rocha RM; Carpinetti PA; Camargo AA; Hoffmann C; Freitas HC; Silva IT; Nunes DN; Setubal JC; Dias-Neto E
Front Cell Infect Microbiol; 2016; 6():179. PubMed ID: 28018861
[TBL] [Abstract][Full Text] [Related]
5. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.
Park JH; Powell AG; Roxburgh CS; Horgan PG; McMillan DC; Edwards J
Br J Cancer; 2016 Mar; 114(5):562-70. PubMed ID: 26859693
[TBL] [Abstract][Full Text] [Related]
6. High abundance of Lachnospiraceae in the human gut microbiome is related to high immunoscores in advanced colorectal cancer.
Hexun Z; Miyake T; Maekawa T; Mori H; Yasukawa D; Ohno M; Nishida A; Andoh A; Tani M
Cancer Immunol Immunother; 2023 Feb; 72(2):315-326. PubMed ID: 35869338
[TBL] [Abstract][Full Text] [Related]
7. Association of gut microbiome with immune microenvironment in surgically treated colorectal cancer patients.
Han N; Chang HJ; Yeo HY; Kim BC; Kim B; Park SC; Kim J; Park JW; Oh JH
Pathology; 2024 Jun; 56(4):528-539. PubMed ID: 38609782
[TBL] [Abstract][Full Text] [Related]
8. T-cell immunoglobulin and ITIM domain, as a potential immune checkpoint target for immunotherapy of colorectal cancer.
Fathi M; Pustokhina I; Kuznetsov SV; Khayrullin M; Hojjat-Farsangi M; Karpisheh V; Jalili A; Jadidi-Niaragh F
IUBMB Life; 2021 May; 73(5):726-738. PubMed ID: 33686787
[TBL] [Abstract][Full Text] [Related]
9. The intestinal microbiota in colorectal cancer metastasis - Passive observer or key player?
Patel M; McAllister M; Nagaraju R; Badran SSFA; Edwards J; McBain AJ; Barriuso J; Aziz O
Crit Rev Oncol Hematol; 2022 Dec; 180():103856. PubMed ID: 36257533
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiota in colorectal cancer: mechanisms of action and clinical applications.
Wong SH; Yu J
Nat Rev Gastroenterol Hepatol; 2019 Nov; 16(11):690-704. PubMed ID: 31554963
[TBL] [Abstract][Full Text] [Related]
11. Microbiome and colorectal carcinogenesis: Linked mechanisms and racial differences.
Tortora SC; Bodiwala VM; Quinn A; Martello LA; Vignesh S
World J Gastrointest Oncol; 2022 Feb; 14(2):375-395. PubMed ID: 35317317
[TBL] [Abstract][Full Text] [Related]
12. Microbe-based management for colorectal cancer.
Gao ZY; Cui Z; Yan YQ; Ning LJ; Wang ZH; Hong J
Chin Med J (Engl); 2021 Dec; 134(24):2922-2930. PubMed ID: 34855639
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
